Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-555-0 | CAS number: 15520-05-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- other: Expert statement
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Expert statement
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
- Objective of study:
- other: ADME
Test guideline
- Qualifier:
- no guideline required
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Absorption:
Based on the subacute (28-day) oral toxicity study absorption of toxicologically significant amounts of Genamin 3920 via the gastrointestinal tract has to be assumed since obvious destruction of the mucous membranes of the inner organs was observed in the stomach.
The dermal irritation as well as dermal toxicity studies indicate some local dermal bioavailability. However, systemic availability seems to be negligible after dermal exposure since no systemic signs of intoxication were seen after occlusive administration of 2000 mg Genamin 3920 per kg body weight in rats in the acute dermal toxicity study. Indications of a significant dermal absorptive potential were also not revealed by testing for primary irritation in rabbits. - Details on distribution in tissues:
- Genamin 3920 is soluble in water as well as in organic solvents and damages the mucous membranes of the gastrointerstinal tract. Thus it can be concluded, that Genamin 3920 is absorbed through the gastrointestinal tract and systemically available within the organism. Histopathological findings indicate no deposition in the affected tissues. There were no signs of bioaccumulation and the solubility indicates a rather quick excretion via the kidneys. This view is supported by the physical-chemical properties (solubility in water) and the molecular structure.
- Details on excretion:
- Taking into account the physico-chemical properties and the molecular structure of the substance as well as the probable metabolites it is assumed that the main route of excretion will be the kidney. A significant fraction of the dose, however, may also be degraded.
Metabolite characterisation studies
- Metabolites identified:
- not specified
- Details on metabolites:
- Metabolism:
Genamin 3920 proved to be inactive in the Ames-test with and without exogenous metabolic activation. It was not genotoxic in the HPRT in vitro and the micronucleus assay in vivo.
No systemic effects were seen in the subacute study. No functional or structural impairments were detected. Nevertheless, the molecular structure indicates a potential for degradation by the liver.
A computational model of the probable metabolism indicates a potential for oxidative dealkylation in alpha-positions meighbouring the nitrogen atom. The resulting metabolites (octanoic acid, diethanolamine and 2-hydorxy-acetic acid) are most probably more easily degraded or exctreted than the mother-compound.
Thus metabolites of Genamin 3920, if any are formed, are not more toxic than the parent compound.
Any other information on results incl. tables
Genamin 3920 proved to be inactive in the Ames-test with and without exogenous metabolic activation. It was not genotoxic in the HPRT in vitro and the micronucleus assay in vivo.
Based on the subacute (28-day) oral toxicity study absorption of toxicologically significant amounts of Genamin 3920 via the gastrointestinal tract has to be assumed since obvious destruction of the mucous membranes of the inner organs was observed in the stomach.
No systemic effects were seen in the sub chronic study (NOAEL 350 mg/kg bw per day). No functional or structural impairments were detected. Nevertheless, the molecular structure indicates a potential for degradation by the liver.
A computational model of the probable metabolism indicates a potential for oxidative dealkylation in alpha-positions meighbouring the nitrogen atom. The resulting metabolites (octanoic acid, diethanolamine and 2-hydorxy-acetic acid) are most probably more easily degraded or exctreted than the mother-compound. Thus metabolites of Genamin 3920, if any are formed, are not more toxic than the parent compound
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): other: no bioaccumulation potential expected
Based on all available data, Genamin 3920 does not exhibit conspicuous toxicokinetic behaviour in the sense of accumulative and/or delayed effects with regard to the individual parameters absorption, distribution, metabolism and excretion.
The results from studies with dermal exposure indicate that Genamin 3920 has a small but definite dermal absorptive potential. Genamin 3920 is most probably absorbed from the gastrointestinal tract in significant amounts.
Indications of an intense metabolism or a bio-accumulative potential do not exist, though the molecular structure indicates a potential for degradation in the organism. Additionally no increase in severity of systemic effects was observed in the subacute oral toxicity study, which also points to no bio-accumulation potential as well as to excretion of Genamin 3920 and/or metabolites. - Executive summary:
Based on the available data base on Genamin 3920 relevant information exists to make a qualitative evaluation of the toxicokinetic profile of this compound. This is in line with animal welfare considerations because additional animal tests can be avoided by such an evaluation.
The results of basic toxicity testing give no reason to anticipate unusual characteristics with regard to the toxicokinetics of Genamin 3920. The data indicate that there is little dermal absorption. On the other hand, Genamin 3920 is absorbed from the gastro-intestinal tract in toxicologically significant amounts. The structure as well as a computational model indicate a potential metabolism mainly via oxidative de-alkylation of the amine. Indications of a bio-accumulative potential as well as a metabolism towards genotoxic sub-structures do not exist. Excretion of systemically available Genamin 3920 and/or metabolites can be assumed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.